KP Tissue (TSE:KPT – Get Free Report) released its quarterly earnings results on Wednesday. The company reported C$0.26 earnings per share for the quarter, FiscalAI reports. The business had revenue of C$560.06 million during the quarter.
Here are the key takeaways from KP Tissue’s conference call:
- Adjusted EBITDA rose 26% YoY to CAD 84.2M in Q4 (revenue CAD 560.1M) and the company returned to positive net income of CAD 23.4M versus a loss a year ago.
- Kruger reported sustained market-share gains in Canada (facial tissue up 130 bps to 46.3%, paper towel up 130 bps to 25.3%) and says the U.S. is its key growth engine with continued distribution wins.
- Operational progress and capacity moves — Sherbrooke insourcing improved AFH margins, a new Memphis converting line is on track for early Q2 2026 startup, and management expects to announce details for a Western U.S. TAD plant (slated for 2028) in H1 2026.
- Management raised 2026 CapEx to CAD 100–120M (includes initial TAD spend), warns pulp prices may rise in 2026, and expects leverage could temporarily rise toward the mid‑4x range during construction — a potential short‑term headwind to shareholder returns.
KP Tissue Stock Performance
KP Tissue stock traded up C$0.01 during mid-day trading on Wednesday, reaching C$10.65. The stock had a trading volume of 1,767 shares, compared to its average volume of 13,006. KP Tissue has a fifty-two week low of C$7.54 and a fifty-two week high of C$10.68. The stock’s 50-day simple moving average is C$10.32 and its 200-day simple moving average is C$9.84. The firm has a market capitalization of C$106.22 million, a PE ratio of 27.31, a price-to-earnings-growth ratio of -0.88 and a beta of 0.33.
Insider Buying and Selling
Analysts Set New Price Targets
Several research firms have commented on KPT. Canadian Imperial Bank of Commerce raised their target price on shares of KP Tissue from C$10.50 to C$11.00 in a report on Friday, November 14th. National Bank Financial raised their target price on KP Tissue from C$10.00 to C$11.00 and gave the company a “sector perform” rating in a report on Monday, February 2nd. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, KP Tissue presently has a consensus rating of “Hold” and a consensus target price of C$10.25.
Read Our Latest Analysis on KPT
About KP Tissue
KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems.
See Also
- Five stocks we like better than KP Tissue
- Energy Security Is Now National Security – Positioning Is Happening Now
- Gilder: Don’t Buy AI Stocks, Do This Instead
- 3 Signs You May Want to Switch Financial Advisors
- ATCX is Sitting on One of Brazil’s Largest Critical Minerals Portfolios!
- Why Q4 Could Destroy Your Wealth
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
